Mercury Laboratories [MERCURYLAB] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Mercury Laboratories Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Mercury Laboratories Ltd. wins in 11 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 0 ties. Mercury Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Mercury Laboratories Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 18.15 73.73 Mercury Laboratories Ltd.
Price-to-Book Ratio 1.54 13.36 Mercury Laboratories Ltd.
Debt-to-Equity Ratio 10.77 27.04 Mercury Laboratories Ltd.
PEG Ratio -1.11 -17.55 Mercury Laboratories Ltd.
EV/EBITDA 10.44 52.76 Mercury Laboratories Ltd.
Profit Margin (TTM) 6.20% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 8.99% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 8.99% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 5.87% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 4.23% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-50.39M $-251.22M Mercury Laboratories Ltd.
Dividend Yield 0.82% 0.17% Mercury Laboratories Ltd.
1-Year Return -11.83% 15.75% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 1.12 22.23 Mercury Laboratories Ltd.
Enterprise Value $887.85M $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 1.17 22.65 Mercury Laboratories Ltd.
Gross Profit Margin (TTM) 61.64% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $635 $15 Mercury Laboratories Ltd.
Earnings per Share (Diluted) $39.30 $4.40 Mercury Laboratories Ltd.
Beta (Stock Volatility) 0.44 -0.17 Gujarat Themis Biosyn Ltd.

Mercury Laboratories Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

MERCURYLAB
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mercury Laboratories Ltd.-2.06%-2.39%-0.16%-5.13%-9.16%-9.32%
Gujarat Themis Biosyn Ltd.-0.57%-4.89%4.00%38.98%-1.40%-12.59%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mercury Laboratories Ltd.-11.83%-5.41%16.63%72.97%2,064.80%2,064.80%
Gujarat Themis Biosyn Ltd.15.75%76.92%76.92%76.92%76.92%76.92%

Performance & Financial Health Analysis: Mercury Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricMERCURYLABGUJTHEM
Market Information
Market Cap i₹855.84M₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1979,452
90 Day Avg. Volume i59106,446
Last Close₹759.00₹385.10
52 Week Range₹620.55 - ₹976.00₹225.05 - ₹479.00
% from 52W High-22.23%-19.60%
All-Time High₹1,303.00 (Jan 08, 2024)₹479.00 (Oct 27, 2025)
% from All-Time High-41.75%-19.60%
Growth Metrics
Quarterly Revenue Growth-0.06%0.10%
Quarterly Earnings Growth-0.16%-0.04%
Financial Health
Profit Margin (TTM) i0.06%0.30%
Operating Margin (TTM) i0.09%0.40%
Return on Equity (TTM) i0.06%0.20%
Debt to Equity (MRQ) i10.7727.04
Cash & Liquidity
Book Value per Share (MRQ)₹464.51₹24.29
Cash per Share (MRQ)₹23.55₹0.92
Operating Cash Flow (TTM) i₹-12,625,000₹970.68M
Levered Free Cash Flow (TTM) i₹31.45M₹487.72M
Dividends
Last 12-Month Dividend Yield i0.82%0.17%
Last 12-Month Dividend i₹7.00₹0.67

Valuation & Enterprise Metrics Analysis: Mercury Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricMERCURYLAB (Apr 26, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i18.1573.73
Forward P/E iN/AN/A
PEG Ratio i-1.11-17.55
Price to Sales (TTM) i1.1222.23
Price to Book (MRQ) i1.5413.36
Market Capitalization
Market Capitalization i₹855.84M₹35.41B
Enterprise Value i₹887.85M₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i1.1722.65
Enterprise to EBITDA i10.4452.76
Risk & Other Metrics
Beta i0.44-0.17
Book Value per Share (MRQ) i₹464.51₹24.29

Financial Statements Comparison: Mercury Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMERCURYLAB (2025)GUJTHEM (2025)
Revenue/Sales i751.01M1.51B
Cost of Goods Sold i289.16M318.78M
COGS % of Revenue i38.5%21.1%
Gross Profit i461.85M1.19B
Gross Margin i61.5%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i74.14M642.49M
Operating Margin i9.9%42.6%
EBITDA i109.74M713.04M
EBITDA Margin i14.6%47.3%
Pre-Tax Income i46.62M655.38M
Pre-Tax Income % of Revenue i6.2%43.5%
Income Tax i15.17M167.66M
Income Tax % of Revenue i2.0%11.1%
Net Income (Profit) i31.45M487.72M
Profit Margin i4.2%32.3%

Balance Sheet & Liquidity Metrics

MetricMERCURYLAB (2025)GUJTHEM (2025)
Cash & Equivalents i3.32M116.94M
Total Current Assets i401.60M519.73M
Total Current Assets % of Revenue i53.5%34.5%
Total Current Liabilities i150.76M205.60M
Total Current Liabilities % of Revenue i20.1%13.6%
Long-Term Debt i37.83M296.36M
Long-Term Debt % of Revenue i5.0%19.7%
Total Shareholders Equity i535.69M2.48B
Retained Earnings i86.56M2.37B
Retained Earnings % of Revenue i11.5%157.4%
Property, Plant & Equipment i85.40M411.30M

Cash Flow Statement Comparison

MetricMERCURYLAB (2025)GUJTHEM (2025)
Operating Cash Flow i-12.63M970.68M
Operating Cash Flow % of Revenue i-1.7%64.4%
Capital Expenditures i-90.40M-1.16B
Free Cash Flow i-50.39M-251.22M
FCF Margin i-6.7%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMERCURYLABGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i1.20M108.97M
Float Shares i165,47029.52M
% Held by Insiders i86.33%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i13.67%26.84%

Dividend Analysis & Yield Comparison: Mercury Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricMERCURYLABGUJTHEM
Last 12-Month Dividend i₹7.00₹0.67
Last 12-Month Dividend Yield i0.82%0.17%
3-Year Avg Annual Dividend i₹4.67₹0.22
3-Year Avg Dividend Yield i0.43%0.17%
3-Year Total Dividends i₹14.00₹0.67
Ex-Dividend DateAug 06, 2025Sep 04, 2025